South Korea has begun its first container ship trial through the Arctic to Europe. The 2,758-TEU PanStar Acro left Busan New Port at about 9 p.m. on August 22. The Ministry of Oceans and Fisheries confirmed the departure and published
Moderna has started a Phase 1 trial of an experimental vaccine against Bundibugyo ebolavirus in Canada. The first participant received the mRNA-1469 vaccine on August 3 at a site in Truro, Nova Scotia. The trial comes as the virus continues
